Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Theriva Biologics Inc (AMEX: TOVX) closed at $0.21 down -2.10% from its previous closing price of $0.22. In other words, the price has decreased by -$2.10 from its previous closing price. On the day, 1.32 million shares were traded. TOVX stock price reached its highest trading level at $0.2218 during the session, while it also had its lowest trading level at $0.21.
Ratios:
For a deeper understanding of Theriva Biologics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.31.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 7665857 and an Enterprise Value of 2481275.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.56, which has changed by -0.86 over the last 52 weeks, in comparison to a change of 0.19362879 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $2.03, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is -9.86%, while the 200-Day Moving Average is calculated to be -58.28%.
Shares Statistics:
For the past three months, TOVX has traded an average of 18.54M shares per day and 18734240 over the past ten days. A total of 35.69M shares are outstanding, with a floating share count of 34.88M. Insiders hold about 2.27% of the company’s shares, while institutions hold 1.22% stake in the company. Shares short for TOVX as of 1765756800 were 5061825 with a Short Ratio of 0.27, compared to 1763078400 on 2084562. Therefore, it implies a Short% of Shares Outstanding of 5061825 and a Short% of Float of 15.020000999999999.
Earnings Estimates
The stock of Theriva Biologics Inc (TOVX) is currently in the spotlight, with 1 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$2.15 and -$2.15 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$0.75, with 1.0 analysts recommending between -$0.75 and -$0.75.
